fundvisualizer.com

T. Rowe Price Glbl Val Eq Cl IPRIGX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
57.67%
Non-U.S. Stock
37.20%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.56%
Convertible
0.00%
Cash
4.58%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

7.58%

Consumer cyclical

4.70%

Financial services

17.42%

Real estate

0.00%

Consumer defensive

6.33%

Health care

19.09%

Utilities

7.16%

Communication services

5.10%

Energy

8.43%

Industrials

10.86%

Technology

8.18%

Top 10 holdings

As of 12/31/2022

Trp Government Reserve
4.14%
Johnson & Johnson
2.40%
UnitedHealth Group Inc
2.22%
Southern Co
2.17%
Chevron Corp
2.13%
AbbVie Inc
2.00%
Becton, Dickinson and Co
1.99%
TotalEnergies SE
1.94%
AstraZeneca PLC
1.91%
Chubb Ltd
1.86%
Fund assets

$105.92 Million

Share class

Inv

Morningstar category

Global Large-Stock Value

Expense ratio

0.68%

Investment objective

World Stock

Documents